Category: 온디맨드 웨비나

Key Highlights:

The educational webinar will present the process of obtaining market access and reimbursement in the US, France and Germany as well as on the upcoming a Joint Clinical Assessment (JCA) process. In the US, we will be discussing the stakeholders that are involved in product access given the fragmented US payer system (e.g. Commercial, Medicare, … Continued

Nonclinical scientists in drug development have volumes of data to analyze and interpret. Visualization is a key tool in their toolbox, allowing for the detection of signals and outliers. SEND datasets are ideal for powering these visualizations. Learn how to turn this regulatory dataset into a engine for internal decision-making with SEND Explorer.

Compared to the Phoenix software installed on local computers, Phoenix Hosted gives research teams much better application performance, flexible access from PC or Mac environments, and comes pre-installed, pre-licensed, and pre-validated. Phoenix Hosted offers scalable hardware to any number of users in a personal workspace for each user. Teams can quickly adopt the latest version … Continued

When a pharmaceutical company faces the end of a product’s patent life, it encounters a myriad of challenges, including the need to overhaul its marketing and sales strategies. This session delves deep into these challenges, emphasizing how companies can pivot towards enhancing the marketing of their existing, patented products. The webinar will provide insights into … Continued

PK analysis intended for submission contends with many data and compliance challenges. To work efficiently, analysts need a method and toolset that: Join us to explore a workflow that offers these benefits in a secure, cloud-hosted environment. We’ll follow a non-compartmental analysis from end-to-end to highlight best practices for data preparation, modeling, and submission readiness. … Continued

Topics covered: 발표자 Gilbert HunterCustomer Success ManagerPinnacle 21 by Certara Erin ErginerDirector of ProductPinnacle 21 by Certara

What does it take to industrialize QSP? What is the right mix of technology and domain expertise to integrate at scale? Join Certara’s Piet van der Graaf, formerly Applied BioMath’s John Burke and Joshua Apgar for insightful and interactive webinar as we share details of our vision for the next generation of QSP. Hear about … Continued

Master clinical phase transitions with insights from industry leaders! Join Piet van der Graaf, SVP and Head of QSP, Hugo Geerts, Head of Neuroscience Modeling QSP, Mirjam Trame, VP of Certara Drug Development Solutions, and Julie M. Bullock, PharmD, SVP of Drug Development Services at Certara. We are thrilled to welcome keynote speaker and panelist … Continued

Secondary pharmacology profiling involves the screening of small molecule compounds against a broad range of targets in order to try to predict off-target interactions leading to safety issues in humans. To date, this has generally required an opinion-based approach, but opinions vary and are inherently unreliable. To evaluate this quantitatively requires the use of surrogate … Continued